Updates are available Correction dated 2021-10-30
Click to view Correction: https://doi.org/10.1007/s00432-021-03830-0
-
Authors
Jurkovic Mlakar, Simona
Uppugunduri, Satyanarayana Chakradhara Rao
Nava, Tiago
Mlakar, Vid
Golay, Hadrien
Robin, Shannon
Waespe, Nicolas
Rezgui, Mohamed Aziz
Chalandon, Yves
Boelens, Jaap Jan
Bredius, Robert G. M.
Dalle, Jean-Hugues
Peters, Christina
Corbacioglu, Selim
Bittencourt, Henrique
Krajinovic, Maja
Ansari, Marc http://orcid.org/0000-0002-9649-6498
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01257854 at ClinicalTrials.govDocuments that mention this clinical trial
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
https://doi.org/10.1007/s00432-021-03769-2
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (ME9870/320030-153389)
Oak Foundation (OCAY-17-642)
Université de Genève
- License Information
-
More Information
Article History
Received: 6 July 2021
Accepted: 14 August 2021
First Online: 9 September 2021
Change Date: 30 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00432-021-03830-0
Declarations
:
: The authors declare that they have no competing interests related to the submitted work.
: The Institutional Review Board or ethics committees approved the study.
: All patients and/or parents provided informed consent.
: All authors are aware of the study and approve of this submission.
